Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

mRNA 1944

Drug Profile

mRNA 1944

Alternative Names: mRNA encoding Chikungunya antibody; mRNA-1944

Latest Information Update: 16 Sep 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Moderna Therapeutics
  • Class Antivirals; RNA
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Chikungunya virus infections

Most Recent Events

  • 12 Sep 2019 Topline immunogenicity and adverse events data from a phase I trial in Chikungunya virus infections released by Moderna Therapeutics
  • 22 Jan 2019 Phase-I clinical trials in Chikungunya virus infections (Prevention) in USA (IV)
  • 11 Jul 2018 Moderna plans to submit an IND application for a phase I trial to USFDA for Chikungunya virus infections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top